Lexicon Pharmaceuticals (LXRX) Times Interest Earned (2010 - 2026)
Lexicon Pharmaceuticals' (LXRX) quarterly Times Interest Earned came in at -$0.23 in Q1 2026, up 97.32% year-on-year from -$0.12 in Q1 2025, and up 96.82% on a QoQ basis from -$7.28 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Times Interest Earned (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 17 years of Times Interest Earned data on file, last reported at -$0.23 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 97.32% year-over-year to -$0.23 in Q1 2026; TTM through Mar 2026 was -$5.63, a 50.71% increase from a year earlier, with the FY2025 full-year figure at -$4.2, down 796.92% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.23, up from -$7.28 in the prior quarter.
- Over the last five years, Times Interest Earned for LXRX reached as high as $0.47 in Q2 2025 and fell as low as -$212.55 in Q1 2022.
- Historically, Times Interest Earned has averaged -$22.94 across 5 years, with a median of -$8.65 in 2025.
- Across the five-year window, Times Interest Earned slumped 307.45% in 2024 and soared 101.89% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$30.04 in 2022, then soared by 71.3% to -$8.62 in 2023, then jumped by 34.36% to -$5.66 in 2024, then fell by 28.6% to -$7.28 in 2025, then surged by 96.82% to -$0.23 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.23 in Q1 2026, -$7.28 in Q4 2025, and -$2.71 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn | -0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.23 |
| Dec 31, 2025 | -7.28 |
| Sep 30, 2025 | -2.71 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | -8.65 |
| Dec 31, 2024 | -5.66 |
| Sep 30, 2024 | -13.96 |
| Jun 30, 2024 | -25.04 |
| Mar 31, 2024 | -9.16 |
| Dec 31, 2023 | -8.62 |
| Sep 30, 2023 | -4.81 |
| Jun 30, 2023 | -6.14 |
| Mar 31, 2023 | -17.10 |
| Dec 31, 2022 | -30.04 |
| Sep 30, 2022 | -26.73 |
| Jun 30, 2022 | -11.84 |
| Mar 31, 2022 | -212.55 |
| Dec 31, 2021 | -272.37 |
| Sep 30, 2021 | -134.28 |
| Jun 30, 2021 | -106.27 |